Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

LifeStance Health Gr Sees Q2 Sales $332.000M-$352.000M vs $352.76M Est

Author: Benzinga Newsdesk | May 07, 2025 05:11am
LifeStance Health Gr (NASDAQ:LFST) sees Q2 sales of $332.000 million-$352.000 million vs $352.76 million analyst estimate.

Posted In: LFST

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist